Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Leads Biolabs’ LBL‑024 Granted Second FDA Fast Track Designation – Bispecific PD‑L1/4‑1BB Antibody Advances in First‑Line Advanced Biliary Tract Cancer

Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) announced that LBL‑024 has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the first-line treatment of advanced…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.